Results 101 to 110 of about 8,934 (195)

Parental occupations at birth and risk of adult testicular germ cell tumors in offspring: a French nationwide case–control study

open access: yesFrontiers in Public Health
BackgroundTesticular germ cell tumors (TGCT) are the most frequent cancer in young men in developed countries. Parental occupational exposures during early-life periods are suspected to increase TGCT risk.
Adèle Paul   +26 more
doaj   +1 more source

Animal models of TGCT and correlation to human histologic subtypes.

open access: yes, 2013
TGCTs appear to arise from embryonic germ cells (EGC) in infants and young children (“type I”) or in adolescents and young adults (“type II”) [4]. (For clarity, the presumed carcinoma in situ precursor cell for type II tumours is omitted).
James F. Amatruda (79531)   +1 more
core   +1 more source

Comprehensive characterization of cancer‐testis genes in testicular germ cell tumor

open access: yesCancer Medicine, 2019
Cancer‐testis (CT) genes are a group of genes restrictedly expressed in testis and multiple cancers and can serve as candidate driver genes participating in the development of cancers.
Yuting Chang   +15 more
doaj   +1 more source

MicroRNA-371–373 cluster extracellular vesicle-based communication in testicular germ cell tumors

open access: yesCell Communication and Signaling
Testicular germ cell tumors (TGCTs) represent the most common type of cancer in young adults. The cluster of microRNAs 371–373 is highly upregulated in TGCTs, and detection of miR-371a-3p specifically is currently being developed for clinical ...
Nuno Tiago Tavares   +13 more
doaj   +1 more source

Phosphoribosyl transferase domain containing 1: A prognostic biomarker in testicular germ cell tumors

open access: yesMolecular Therapy: Oncology
Due to the heterogeneity and complex classification of testicular germ cell tumors (TGCTs), prognostic evaluation and therapeutic targets remain unclear.
Peisheng Huang   +11 more
doaj   +1 more source

Gene-expression signatures as prognostic for relapse in stage I testicular germ cell tumors (TGCT).

open access: yes, 2016
493 Background: Genomic signatures may compliment pathological features in identifying appropriate patients who may benefit from adjuvant therapy in Stage I (SI) TGCT.
Robert James Hamilton   +12 more
core   +1 more source

Tenosynovial Giant Cell Tumor: Incidence, Prevalence, Patient Characteristics, and Recurrence. A Registry-based Cohort Study in Denmark

open access: yes, 2017
Objective.Tenosynovial giant cell tumor (TGCT) is a rare benign proliferative and inflammatory disease arising from synovia of joints, bursae, or tendon sheaths.
John F. Acquavella   +6 more
core   +1 more source

Origin and evolution of TGCTs [PDF]

open access: yesNature Reviews Urology, 2016
openaire   +1 more source

c-MET activated pathways and their implication in TGCTs oncogenesis

open access: yes, 2020
HGF/C-MET system has a very intricate signalling whose importance is well known during embryogenesis. c-MET de-regulation is widely described in several human cancers, and for this purpose, it is used as a target in several personalized therapies (www.vai.org/met). Though, few data are present in literature about this system in TGCTs.
openaire   +1 more source

Home - About - Disclaimer - Privacy